Skip to main content

Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program.

Publication ,  Journal Article
Roth, MT; Westman, EC
Published in: Pharmacotherapy
May 2001

We administered bupropion sustained-release (SR) in a pharmacist-managed outpatient smoking-cessation program. Patients were referred to the program by their primary care physician. All patients completed initial visit questionnaires, received behavioral counseling by a clinical pharmacist, and were provided educational materials on smoking cessation. Seventy-one patients received bupropion SR for treatment of nicotine dependence and were followed for 6 months. Point prevalence abstinence rates were 28.2% and 25.4% at 8 weeks and 6 months, respectively. The trend was toward lower cessation rates in patients with a documented psychiatric diagnosis at 6 months (p=0.064). Bupropion SR was fairly well tolerated, with the most common adverse effects being dry mouth and bad taste. The agent appears to have better success for smoking cessation in patients free of psychiatric comorbidities, but further research is required to support this finding.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

May 2001

Volume

21

Issue

5

Start / End Page

636 / 641

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Smoking Cessation
  • Smoking
  • Recurrence
  • Pharmacology & Pharmacy
  • Pharmacists
  • Outcome Assessment, Health Care
  • Odds Ratio
  • Middle Aged
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Roth, M. T., & Westman, E. C. (2001). Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy, 21(5), 636–641. https://doi.org/10.1592/phco.21.6.636.34548
Roth, M. T., and E. C. Westman. “Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program.Pharmacotherapy 21, no. 5 (May 2001): 636–41. https://doi.org/10.1592/phco.21.6.636.34548.
Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001 May;21(5):636–41.
Roth, M. T., and E. C. Westman. “Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program.Pharmacotherapy, vol. 21, no. 5, May 2001, pp. 636–41. Pubmed, doi:10.1592/phco.21.6.636.34548.
Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001 May;21(5):636–641.

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

May 2001

Volume

21

Issue

5

Start / End Page

636 / 641

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Smoking Cessation
  • Smoking
  • Recurrence
  • Pharmacology & Pharmacy
  • Pharmacists
  • Outcome Assessment, Health Care
  • Odds Ratio
  • Middle Aged
  • Humans